Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial.

ABSTRACT:

SUBMITTER: Zuo J 

PROVIDER: S-EPMC11492360 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature